MAPK1 and renal carcinoma: IPA confirmed that the target molecules identified in our study (ERK, FOXO1, FOXO3, JNK1, PDCD4, AKT3) form an interactive network with shikonin, which further leads to renal cancer, renal cell carcinoma, and apoptosis (Figure S1).